Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03043664
Title Study of Pembrolizumab With Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)
Acronym PLANET
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Duke University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.